These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33486086)

  • 1. Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
    Bryson AE; Cabral HJ; Coles MS
    J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):525-529. PubMed ID: 33486086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-Up Care and 6-Month Continuation Rates for Long-Acting Reversible Contraceptives in Adolescents and Young Adults: A Retrospective Chart Review.
    Jones AE; Kaul S; Harding J; Weldon DLM; Akers AY
    J Pediatr Adolesc Gynecol; 2020 Feb; 33(1):39-44. PubMed ID: 31513921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting.
    Howard DL; Ford A; Ceballos S; Volker KW
    J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year continuation of reversible contraception.
    Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
    Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long acting reversible contraception in adolescents with cardiovascular conditions.
    Amies Oelschlager AM; Micks EA; Debiec KE; Nizamic T; Mantrala MD; Prager SW
    J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):353-5. PubMed ID: 25256877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.
    Sanders JN; Turok DK; Gawron LM; Law A; Wen L; Lynen R
    Am J Obstet Gynecol; 2017 Jun; 216(6):590.e1-590.e8. PubMed ID: 28188772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telemedicine for Adolescent and Young Adult Long-Acting Reversible Contraception Post-insertion Visits: Outcomes over 1 Year.
    Bryson AE; Milliren CE; Golub SA; Maslyanskaya S; Escovedo M; Borzutzky C; Pitts SAB; DiVasta AD
    J Pediatr Adolesc Gynecol; 2024 Aug; 37(4):438-443. PubMed ID: 38679156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
    Agostini A; Godard C; Laurendeau C; Benmahmoud Zoubir A; Lafuma A; Lévy-Bachelot L; Gourmelen J; Linet T
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):421-426. PubMed ID: 30499732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
    Tocce K; Sheeder J; Python J; Teal SB
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
    Diedrich JT; Klein DA; Peipert JF
    Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
    Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telemedicine for Adolescent and Young Adult Long-Acting Reversible Contraception Follow-Up Care amidst a Global Pandemic.
    Bryson AE; Milliren CE; Borzutzky C; Golub SA; Pitts SAB; DiVasta AD
    J Pediatr Adolesc Gynecol; 2023 Feb; 36(1):51-57. PubMed ID: 35948207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young Age, Nulliparity, and Continuation of Long-Acting Reversible Contraceptive Methods.
    Abraham M; Zhao Q; Peipert JF
    Obstet Gynecol; 2015 Oct; 126(4):823-829. PubMed ID: 26348177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subdermal Contraceptive Implant Insertion Trends and Retention in Adolescents.
    Tyson N; Lopez M; Merchant M; Postlethwaite D
    J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):348-354. PubMed ID: 33388444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
    Morgan IA; Zapata LB; Curtis KM; Whiteman MK
    J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-month continuation of reversible contraception.
    O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
    Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and the choice of long-acting reversible contraception following medical abortion: effect on subsequent induced abortion and unwanted pregnancy.
    Korjamo R; Heikinheimo O; Mentula M
    Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):89-96. PubMed ID: 29537321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.